Imatinib May Be ABL to Improve Anti-Angiogenic Therapy
Molecular and Cellular Oncology - United Kingdom
doi 10.4161/23723548.2014.968034
Full Text
Open PDFAbstract
Available in full text
Date
January 2, 2015
Authors
Publisher
Informa UK Limited
Available in full text
January 2, 2015
Informa UK Limited